Palisade Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.02

+0.05 (+2.54%)

As of Jul 4, 2:06 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +117.8% upside

Low Target $2.36

Average Target $4.40

High Target $4.89

Current Price $2.02

Current
$2.02

Target
$4.40

$2.36 $4.40 avg $4.89

Scenario Analysis

Bear Case

$2.36

16.8%

Low target

Base Case

$4.40

+117.8%

Avg target

Bull Case

$4.89

+142.1%

High target

Risk/Reward

8.4x

Highly favorable

Price in Context

52-Week High

$2.86

-29.2% from high

52-Week Low

$0.53

+281.1% from low

Target vs 52W High

$4.40

+54.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%